CEA, the most widely used tumor marker for CRC, is elevated in 60%–85 % of cases [8,11], with specificity ranging from 70 % to 90 % but sensitivity limited to 35%–75 % [30,31]. The gene discussed is CEACAM5; the disease is colorectal carcinoma.